The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Cancer Nanovaccines
In article number 2104849, Mi Liu and co‐workers demonstrate a simple and universal method to prepare therapeutic and preventive cancer nanovaccines based on tumor tissues/cells. Such nanovaccines show both potent preventive and potent therapeutic efficacy in lung cancer, melanoma, and breast cancer. This universal method can be applied to make tumor‐cell‐based nanovaccines for...
Tumor tissues/cells are the best sources of antigens to prepare cancer vaccines. However, due to the difficulty of solubilization and delivery of water‐insoluble antigens in tumor tissues/cells, including water‐insoluble antigens into cancer vaccines and delivering such vaccines efficiently to antigen‐presenting cells (APCs) remain challenging. To solve these problems, herein, water‐insoluble components...